Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Very encouraging, if it weren't for incompetent and self-serving management of the company over the last five years, we would likely be at least valued as much as Aduro's $700 million market cap, which is around a $14 share price for ADXS. With the right business deal, hopefully Berlin will get us there soon. He has the science on his side (then again so did O'Connor, but he chose to use it for self enrichment at the expense of the interests of his investors).